Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | ACACB | O00763 | 1/20 | 0.41 |
| ▸ | ACACA | Q13085 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.37 |
| ▸ | GMNN | O75496 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | THPO | P40225 | 1/20 | 0.37 |
| ▸ | MTOR | P42345 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25303278 | 1.00 | THRB (0.59) | THRBLMNAALDH1A1USP2CYP3A4 | |
| SCHEMBL9278178 | 1.00 | THRB (0.59) | THRBLMNAALDH1A1USP2CYP3A4 | |
| SCHEMBL22395412 | 1.00 | THRB (0.59) | THRBLMNAALDH1A1USP2CYP3A4 | |
| SCHEMBL25389134 | 1.00 | THRB (0.59) | THRBLMNAALDH1A1USP2CYP3A4 | |
| SCHEMBL1164867 | 0.96 | THRB (0.62) | THRBLMNAALDH1A1USP2CYP3A4 | |
| SCHEMBL3969645 | 0.91 | THRB (0.58) | THRBLMNAALDH1A1USP2CYP3A4 | |
| SCHEMBL6235810 | 0.91 | THRB (0.50) | THRBLMNAALDH1A1USP2CYP3A4 | |
| SCHEMBL8624500 | 0.91 | THRB (0.58) | THRBLMNAALDH1A1USP2CYP3A4 | |
| SCHEMBL11695104 | 0.91 | THRB (0.58) | THRBLMNAALDH1A1USP2CYP3A4 | |
| SCHEMBL3967156 | 0.91 | THRB (0.58) | THRBLMNAALDH1A1USP2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4504883-B1 | FABRIC TREATMENT COMPOSITIONS WITH ANTIOXIDANT MULTIMERS | PROCTER & GAMBLE (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-4504883-A1 | FABRIC TREATMENT COMPOSITIONS WITH ANTIOXIDANT MULTIMERS | The Procter & Gamble Company (US) | 2025-02-12 | — | — | EP | disclosed |
| EP-4463534-A1 | TREATMENT COMPOSITIONS WITH MODIFIED AMINO ACID MULTIMERS | The Procter & Gamble Company (US) | 2024-11-20 | — | — | EP | disclosed |
| US-20230323250-A1 | FABRIC TREATMENT COMPOSITIONS WITH ANTIOXIDANT MULTIMERS | THE PROCTER & GAMBLE COMPANY | 2023-10-12 | — | — | US | disclosed |
| WO-2023196452-A1 | FABRIC TREATMENT COMPOSITIONS WITH ANTIOXIDANT MULTIMERS | THE PROCTER & GAMBLE COMPANY (US) | 2023-10-12 | — | — | WO | disclosed |
| WO-2023137409-A1 | TREATMENT COMPOSITIONS WITH MODIFIED AMINO ACID MULTIMERS | THE PROCTER & GAMBLE COMPANY (US) | 2023-07-20 | — | — | WO | disclosed |
| US-20230220300-A1 | TREATMENT COMPOSITIONS WITH MODIFIED AMINO ACID MULTIMERS | THE PROCTER & GAMBLE COMPANY | 2023-07-13 | — | — | US | disclosed |
| CN-105968001-B | Carboxyl group-containing reactive compound, curable resin composition using same, and cured product | 日本化药株式会社 | 2020-05-08 | — | — | CN | disclosed |
| EP-1210055-B1 | TWO-CONSTITUENT ELASTOMER MATERIALS BASED ON ALKYL AZIRIDINE COMPRISING A CATALYST CONSTITUENT THAT CONTAINS A BORIC ACID COMPLEX | 3M ESPE AG (DE) | 2006-11-22 | — | — | EP | disclosed |
| EP-1706437-A1 | DUAL METALLOCENE CATALYST FOR PRODUCING FILM RESINS WITH GOOD MACHINE DIRECTION (MD) ELMENDORF TEAR STRENGTH | Chevron Phillips Chemical Company LP (US) | 2006-10-04 | — | — | EP | disclosed |
| WO-2005070977-A1 | DUAL METALLOCENE CATALYST FOR PRODUCING FILM RESINS WITH GOOD MACHINE DIRECTION (MD) ELMENDORF TEAR STRENGTH | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2005-08-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230220300-A1 | TREATMENT COMPOSITIONS WITH MODIFIED AMINO ACID MULTIMERS | BCAT2, MTR, ASNS | THRB 4774/4885LMNA 793/4885ALDH1A1 3811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.